Efficacy and Safety of Neoadjuvant Pyrotinib for Human Epidermal Receptor 2-Positive Breast Cancer: A Meta-Analysis

Tohoku J Exp Med. 2024 Apr 25. doi: 10.1620/tjem.2024.J026. Online ahead of print.
No abstract available